Enzyme-based products of BLG Group are recognized by clinical nutrition experts
2023-10-13 17:08:01 300538 Source: Sohu.com
On October 10, 2023, the "Beijing Clinical Nutrition Therapy Quality Control Center Work Conference" was successfully held in Beijing, hosted by Beijing Clinical Nutrition Therapy Quality Control and Improvement Center, and co-organized by Enzyme Good Life Group (China) Co., Ltd. and Zhongguancun Health Service Industry Promotion Association. The conference brought together more than 150 experts and scholars in the field of clinical nutrition from various hospitals in Beijing. They discussed the development trend of clinical nutrition therapy and shared the latest research results of clinical nutrition therapy.
The meeting was chaired by Fang Jinghui, deputy director of Beijing Clinical Nutrition Therapy Quality Control and Improvement Center. Yu Kang, director of the Department of Clinical Nutrition and the Department of Health Medicine of Peking Union Medical College Hospital, and director of the Beijing Clinical Nutrition Quality Control Center, reported on the quality control work in 2022-2023. He also explained the development and innovation of the clinical nutrition department under the DRG model.
Fang Yu, director of the Clinical Nutrition Department of Peking University Cancer Hospital, Zhao Xia, Beijing Jishuitan Hospital, and other experts explained to the participants in different fields, including the interpretation of the Expert Consensus on Medical Nutrition Management of Dyslipidemia, nutrition diagnosis and quality control management, the latest medical progress in IBD nutrition therapy, nutrition food management for AIDS patients, and nutrition therapy research for stem cell transplant patients. They let everyone know that as clinical nutrition plays an increasingly important role in the process of disease prevention and treatment, its standardized and standardized development is also receiving more and more attention, and the demand for nutrition therapy in clinical work is also growing, from "assistant" to "main force".
Dr. Zhou Xunyong, Chairman of BLG Group (China) Co., Ltd., attended the conference as a special guest, shared the innovation and development of enzyme-based immune balance theory, and brought the latest research results of enzyme-based products.
Dr. Zhou Xunyong brought the most cutting-edge enzyme-based immune balance theory products. Dr. Zhou Xunyong pointed out that the human body contains a variety of enzymes with different functions, which constitute a huge biological enzyme system, and participate in all metabolic activities in the life process in a precise way, control the laws of the life activities of the entire body, and can make the cell material metabolism process in the body proceed in an orderly manner, so that material metabolism, energy metabolism and normal physiological function activities can adapt to each other. It is also closely related to the immune system, immune organs, immune cells and cell function balance. The enzyme balance in immune cells directly or indirectly affects the function of the immune system and constitutes the key points of enzyme-based immune balance.
After in-depth understanding, the experts fully realized the importance of enzyme-based immune balance and expressed that the concepts and products proposed by EnzymeHealth Group will have a profound impact on the development of clinical nutrition and the way of thinking of practitioners in the field of clinical nutrition.
BLG Group, headquartered in Shuyang County National Economic Development Zone, due to strategic development needs, BLG China Group will invest RMB 1 billion in Shuyang County National Economic Development Zone, Jiangsu Province in 2023 to build a modern visual production base.
BLG Group focuses on solving human health problems based on the theory of enzyme-based immune balance and advanced biotechnology. Through this conference, EnzymeLife Group's products have been unanimously recognized and praised by experts in the Beijing nutrition field. BLG Group has established close ties with experts and scholars in the field of clinical nutrition to jointly explore how to apply the theory of enzyme-based immune balance to the field of clinical nutrition and make more contributions to the formulation of the next clinical nutrition guidelines to improve people's health level and quality of life.